Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry

Journal of Virology

Volumn 85, Issue 20, 2011, Pages 10509-10517

  Aoki, Scott T ^a,e   Trask, Shane D ^a,f   Coulson, Barbara S ^b   Greenberg, Harry B ^c   Dormitzer, Philip R ^a,g   Harrison, Stephen C ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g Novartis Vaccines and Diagnostics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SARCIN; DISULFIDE; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; PROTEIN VP7;

ARTICLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN STRUCTURE; ROTAVIRUS; VIRION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS UNCOATING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; DISULFIDES; MACACA MULATTA; ROTAVIRUS; VIRUS INTERNALIZATION;

MIRIDAE; ROTAVIRUS;

EID: 80055006994     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00234-11     Document Type: Article

References (61)

1. Aoki, S. T., et al. 2009. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 324:1444-1447.
2. Chen, D., and R. F. Ramig. 1993. Rescue of infectivity by sequential in vitro transcapsidation of rotavirus core particles with inner capsid and outer capsid proteins. Virology 194:743-751.
3. Chen, J. Z., et al. 2009. Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM. Proc. Natl. Acad. Sci. U. S. A. 106:10644-10648.
4. Clark, S. M., J. R. Roth, M. L. Clark, B. B. Barnett, and R. S. Spendlove. 1981. Trypsin enhancement of rotavirus infectivity: mechanism of enhancement. J. Virol. 39:816-822.
5. Cohen, J., J. Laporte, A. Charpilienne, and R. Scherrer. 1979. Activation of rotavirus RNA polymerase by calcium chelation. Arch. Virol. 60:177-186.
6. Crawford, S. E., et al. 1999. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J. Virol. 73: 4813-4822.
7. Cuadras, M. A., C. F. Arias, and S. Lopez. 1997. Rotaviruses induce an early membrane permeabilization of MA104 cells and do not require a low intracellular Ca2+ concentration to initiate their replication cycle. J. Virol. 71: 9065-9074.
8. Denisova, E., et al. 1999. Rotavirus capsid protein VP5* permeabilizes membranes. J. Virol. 73:3147-3153.
9. Dormitzer, P. R., G. W. Both, and H. B. Greenberg. 1994. Presentation of neutralizing epitopes by engineered rotavirus VP7's expressed by recombinant vaccinia viruses. Virology 204:391-402.
10. Dormitzer, P. R., and H. B. Greenberg. 1992. Calcium chelation induces a conformational change in recombinant herpes simplex virus-1-expressed rotavirus VP7. Virology 189:828-832.
11. Dormitzer, P. R., H. B. Greenberg, and S. C. Harrison. 2001. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core. J. Virol. 75:7339-7350.
12. Dormitzer, P. R., H. B. Greenberg, and S. C. Harrison. 2000. Purified recombinant rotavirus VP7 forms soluble, calcium-dependent trimers. Virology 277:420-428.
13. Dormitzer, P. R., D. Y. Ho, E. R. Mackow, E. S. Mocarski, and H. B. Greenberg. 1992. Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. Virology 187:18-32.
14. Dormitzer, P. R., E. B. Nason, B. V. Prasad, and S. C. Harrison. 2004. Structural rearrangements in the membrane penetration protein of a nonenveloped virus. Nature 430:1053-1058.
15. Ekiert, D. C., et al. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
16. Emini, E. A., S. Y. Kao, A. J. Lewis, R. Crainic, and E. Wimmer. 1983. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. J. Virol. 46:466-474.
17. Emini, E. A., P. Ostapchuk, and E. Wimmer. 1983. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization. J. Virol. 48:547-550.
18. Espejo, R. T., S. Lopez, and C. Arias. 1981. Structural polypeptides of simian rotavirus SA11 and the effect of trypsin. J. Virol. 37:156-160.
19. Estes, M., and A. Z. Kapikian. 2007. Rotaviruses, p. 1918-1974. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed. Lippincott, Williams & Wilkins, Philadelphia, PA.
20. Estes, M. K., D. Y. Graham, and B. B. Mason. 1981. Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J. Virol. 39:879-888.
21. Feng, N., J. W. Burns, L. Bracy, and H. B. Greenberg. 1994. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:7766-7773.
22. Fiore, L., et al. 1995. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus. J. Gen. Virol. 76(Pt. 8):1981-1988.
23. Fiore, L., H. B. Greenberg, and E. R. Mackow. 1991. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181:553-563.
24. Gajardo, R., P. Vende, D. Poncet, and J. Cohen. 1997. Two proline residues are essential in the calcium-binding activity of rotavirus VP7 outer capsid protein. J. Virol. 71:2211-2216.
25. Gorrell, R. J., and R. F. Bishop. 1999. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children. J. Med. Virol. 57:204-211.
26. Graenicher, D., and H. Portzehl. 1964. The influence of magnesium and calcium pyrophosphate chelates, of free magnesium ions, free calcium ions, and free pyrophosphate ions on the dissociation of actymyosin in solution. Biochim. Biophys. Acta 86:567-578.
27. Graham, D. Y., and M. K. Estes. 1980. Proteolytic enhancement of rotavirus infectivity: biology mechanism. Virology 101:432-439.
28. Green, K. Y., K. Taniguchi, E. R. Mackow, and A. Z. Kapikian. 1990. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J. Infect. Dis. 161:667-679.
29. Gunn, P. R., et al. 1985. Rotavirus neutralizing protein VP7: antigenic determinants investigated by sequence analysis and peptide synthesis. J. Virol. 54:791-797.
30. Hewat, E. A., and D. Blaas. 1996. Structure of a neutralizing antibody bound bivalently to human rhinovirus 2. EMBO J. 15:1515-1523.
31. Icenogle, J., et al. 1983. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. Virology 127:412-425.
32. Jiang, B., et al. 1999. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine 17:1005-1013.
33. Jiang, B., et al. 2008. Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum. Vaccin. 4:143-147.
34. Kaufmann, B., et al. 2006. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody. Proc. Natl. Acad. Sci. U. S. A. 103: 12400-12404.
35. Kim, I. S., S. D. Trask, M. Babyonyshev, P. R. Dormitzer, and S. C. Harrison. 2010. Effect of mutations in VP5 hydrophobic loops on rotavirus cell entry. J. Virol. 84:6200-6207.
36. Lawton, J. A., M. K. Estes, and B. V. Prasad. 2001. Identification and characterization of a transcription pause site in rotavirus. J. Virol. 75:1632-1642.
37. Lazdins, I., et al. 1995. Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7. Virology 209:80-89.
38. Li, Z., M. L. Baker, W. Jiang, M. K. Estes, and B. V. Prasad. 2009. Rotavirus architecture at subnanometer resolution. J. Virol. 83:1754-1766.
39. Liprandi, F., et al. 1997. Productive penetration of rotavirus in cultured cells induces coentry of the translation inhibitor alpha-sarcin. Virology 237:430-438.
40. Ludert, J. E., M. C. Ruiz, C. Hidalgo, and F. Liprandi. 2002. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J. Virol. 76:6643-6651.
41. Mackow, E. R., et al. 1988. Characterization of homotypic and heterotypic VP7 neutralization sites of rhesus rotavirus. Virology 165:511-517.
42. Mackow, E. R., et al. 1988. The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc. Natl. Acad. Sci. U. S. A. 85:645-649.
43. Martin, S., M. Lorrot, M. A. El Azher, and M. Vasseur. 2002. Ionic strengthand temperature-induced K(Ca) shifts in the uncoating reaction of rotavirus strains RF and SA11: correlation with membrane permeabilization. J. Virol. 76:552-559.
44. Nybakken, G. E., et al. 2005. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437:764-769.
45. Offit, P. A., R. D. Shaw, and H. B. Greenberg. 1986. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins VP3 and VP7. J. Virol. 58:700-703.
46. Padilla-Noriega, L., et al. 1993. Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J. Clin. Microbiol. 31: 622-628.
47. Parashar, U. D., E. G. Hummelman, J. S. Bresee, M. A. Miller, and R. I. Glass. 2003. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9:565-572.
48. Prasad, B. V., G. J. Wang, J. P. Clerx, and W. Chiu. 1988. Three-dimensional structure of rotavirus. J. Mol. Biol. 199:269-275.
49. Ruggeri, F. M., and H. B. Greenberg. 1991. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J. Virol. 65:2211-2219.
50. Ruiz, M. C., et al. 1996. The concentration of Ca2+ that solubilizes outer capsid proteins from rotavirus particles is dependent on the strain. J. Virol. 70:4877-4883.
51. Santos, N., and Y. Hoshino. 2005. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol. 15:29-56.
52. Settembre, E. C., J. Z. Chen, P. R. Dormitzer, N. Grigorieff, and S. C. Harrison. 2011. Atomic model of an infectious rotavirus particle. EMBO J. 30:408-416.
53. Shaw, R. D., P. T. Vo, P. A. Offit, B. S. Coulson, and H. B. Greenberg. 1986. Antigenic mapping of the surface proteins of rhesus rotavirus. Virology 155:434-451.
54. Smith, T. J., N. H. Olson, R. H. Cheng, E. S. Chase, and T. S. Baker. 1993. Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility. Proc. Natl. Acad. Sci. U. S. A. 90:7015-7018.
55. Sui, J., et al. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16:265-273.
56. Trask, S. D., and P. R. Dormitzer. 2006. Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. J. Virol. 80:11293-11304.
57. Trask, S. D., I. S. Kim, S. C. Harrison, and P. R. Dormitzer. 2010. A rotavirus spike protein conformational intermediate binds lipid bilayers. J. Virol. 84:1764-1770.
58. Wolf, M. M., P. T. Vo, and H. B. Greenberg. 2011. Rhesus rotavirus entry into a polarized epithelium is endocytosis dependent and involves sequential VP4 conformational changes. J. Virol. 85:2492-2503.
59. Wyatt, R. G., et al. 1979. Rotaviral immunity in gnotobiotic calves: heterologous resistance to human virus induced by bovine virus. Science 203:548-550.
60. Yeager, M., K. A. Dryden, N. H. Olson, H. B. Greenberg, and T. S. Baker. 1990. Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J. Cell Biol. 110:2133-2144.
61. Yoder, J. D., et al. 2009. VP5* rearranges when rotavirus uncoats. J. Virol. 83:11372-11377.